Merck KGaA Receives Average 'Hold' Rating from Research Firms

Merck KGaA (OTCMKTS:MKKGY) has received an average rating of 'Hold' from six research firms, according to MarketBeat. Five analysts have given a hold recommendation, while one has assigned a strong buy rating.

The company's healthcare business develops prescription medicines and related services focused on oncology, immunology, neurology, and fertility. Merck KGaA posted $0.59 EPS for the quarter, beating analyst estimates of $0.45 by $0.14. The firm had revenue of $6.03 billion, compared to analyst estimates of $5.93 billion.

Merck KGaA has a market cap of $21.43 billion and a P/E ratio of 14.74. The company has a 1-year high of $34.19 and a 1-year low of $23.73. Research analysts anticipate that Merck KGaA will post 1.87 earnings per share for the current year.